Actively Recruiting
Evaluation of MHB046C Injection for Safety, Tolerability, Pharmacokinetics, and Efficacy in Patients With Advanced Solid Tumors
Led by Minghui Pharmaceutical (Hangzhou) Ltd · Updated on 2026-10-09
200
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating MHB046C, a drug being studied in a first-in-human, open-label, multicenter Phase III trial for patients with advanced solid tumors. The study aims to assess the safety, tolerability, pharmacokinetics, and preliminary efficacy of MHB046C monotherapy, including determining the maximum tolerated dose. This trial involves adults with advanced solid cancers that have not responded to or are intolerant of standard treatments, or have no standard options available. The trial consists of two parts a dose escalation phase followed by an indication expansion phase. In the dose escalation phase, patients receive intravenous MHB046C every three weeks in six escalating dose cohorts to evaluate safety and identify the recommended dose. The indication expansion phase further explores safety and efficacy of MHB046C monotherapy in specific advanced solid tumor types using doses determined in the earlier phase. Treatment continues until unacceptable toxicity or disease progression occurs. Participants will be monitored with assessments including tumor response evaluations by RECIST v1.1, adverse event tracking, and pharmacokinetic testing from before dosing up to several years. Outcome measures include maximum tolerated dose, overall response rate, duration of response, disease control rate, progression-free survival, and overall survival over up to five years. Safety monitoring also includes immunogenicity and long-term follow-up. Participants remain under study care until progression, withdrawal, or loss to follow-up.
CONDITIONS
Brief Title
A Study of MHB046C Injection in Patients With Advanced Solid Tumors
Research Team
V
VP of R&D
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here